Cargando…

NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview

Actively proliferating cancer cells require sufficient amount of NADH and NADPH for biogenesis and to protect cells from the detrimental effect of reactive oxygen species. As both normal and cancer cells share the same NAD biosynthetic and metabolic pathways, selectively lowering levels of NAD(H) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pramono, Alvinsyah Adhityo, Rather, Gulam M., Herman, Herry, Lestari, Keri, Bertino, Joseph R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175141/ https://www.ncbi.nlm.nih.gov/pubmed/32111066 http://dx.doi.org/10.3390/biom10030358

Ejemplares similares

NAT2 Gene rs1041983 is Associated with Anti-Tuberculosis Drug Induced Hepatotoxicity Among Pediatric Tuberculosis in Bandung, Indonesia
por: Headriawan, Achmad, et al.
Publicado: (2021)

Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin
por: Rather, Gulam Mohmad, et al.
Publicado: (2021)

Metabolic and Bactericidal Effects of Targeted Suppression of NadD and NadE Enzymes in Mycobacteria
por: Rodionova, Irina A., et al.
Publicado: (2014)

Enzymology of Ca(2+)-Mobilizing Second Messengers Derived from NAD: From NAD Glycohydrolases to (Dual) NADPH Oxidases
por: Guse, Andreas H.
Publicado: (2023)

Clinical Evidence for Targeting NAD Therapeutically
por: Radenkovic, Dina, et al.
Publicado: (2020)

NAD(+) Homeostasis and NAD(+)-Consuming Enzymes: Implications for Vascular Health
por: Campagna, Roberto, et al.
Publicado: (2023)

A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma
por: Rather, Gulam M., et al.
Publicado: (2019)

Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance Cytometry for Targeted Therapy
por: Lin, Zhongtian, et al.
Publicado: (2020)

In planta study of photosynthesis and photorespiration using NADPH and NADH/NAD(+) fluorescent protein sensors
por: Lim, Shey-Li, et al.
Publicado: (2020)

Architecture of the NADPH oxidase family of enzymes
por: Ogboo, Blessing C., et al.
Publicado: (2022)

NADPH oxidase as a therapeutic target in Alzheimer's disease
por: Block, Michelle L
Publicado: (2008)

Evidence that the nadA motif is a bacterial riboswitch for the ubiquitous enzyme cofactor NAD(+)
por: Malkowski, Sarah N., et al.
Publicado: (2019)

Xrn1 is a deNADding enzyme modulating mitochondrial NAD-capped RNA
por: Sharma, Sunny, et al.
Publicado: (2022)

An engineered enzyme that targets circulating lactate to alleviate intracellular NADH/NAD(+) imbalance
por: Patgiri, Anupam, et al.
Publicado: (2020)

NAD(+)-Consuming Enzymes in Stem Cell Homeostasis
por: Ji, Xiuna, et al.
Publicado: (2023)

NADPH oxidases in traumatic brain injury – Promising therapeutic targets?
por: Ma, Merry W., et al.
Publicado: (2018)

NADPH Oxidase 4: A Potential Therapeutic Target of Malignancy
por: Gong, Shulei, et al.
Publicado: (2022)

NAD Metabolism in Cancer Therapeutics
por: Yaku, Keisuke, et al.
Publicado: (2018)

The –SH Protection Method for Determining Accurate K(d) Values for Enzyme-Coenzyme Complexes of NAD(+)-Dependent Glutamate Dehydrogenase and Engineered Mutants: Evidence for Nonproductive NADPH Complexes
por: Griffin, Joanna, et al.
Publicado: (2010)

Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells
por: Tedeschi, P M, et al.
Publicado: (2013)

Activated matriptase as a target to treat breast cancer with a drug conjugate
por: Rather, Gulam M., et al.
Publicado: (2018)

Selective Detection of NADPH Oxidase in Polymorphonuclear Cells by Means of NAD(P)H-Based Fluorescence Lifetime Imaging
por: Niesner, R., et al.
Publicado: (2008)

Study of NAD-interacting proteins highlights the extent of NAD regulatory roles in the cell and its potential as a therapeutic target
por: Duarte-Pereira, Sara, et al.
Publicado: (2023)

Mono(ADP-ribosyl)ation Enzymes and NAD(+) Metabolism: A Focus on Diseases and Therapeutic Perspectives
por: Poltronieri, Palmiro, et al.
Publicado: (2021)

Toward point-of-care assessment of patient response: a portable tool for rapidly assessing cancer drug efficacy using multifrequency impedance cytometry and supervised machine learning
por: Ahuja, Karan, et al.
Publicado: (2019)

NADPH Oxidase as a Therapeutic Target for Oxalate Induced Injury in Kidneys
por: Joshi, Sunil, et al.
Publicado: (2013)

A second riboswitch class for the enzyme cofactor NAD(+)
por: Panchapakesan, Shanker S.S., et al.
Publicado: (2021)

NAD(+) Degrading Enzymes, Evidence for Roles During Infection
por: Tan, Arnold, et al.
Publicado: (2021)

Exploring the therapeutic space around NAD(+)
por: Houtkooper, Riekelt H., et al.
Publicado: (2012)

Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer
por: Shaik, Tazeem, et al.
Publicado: (2018)

NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
por: Joseph, P., et al.
Publicado: (1998)

Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme
por: Katsuyama, Masato, et al.
Publicado: (2012)

NAD(+)-consuming enzymes in immune defense against viral infection
por: Shang, Jialin, et al.
Publicado: (2021)

NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
por: Xie, Na, et al.
Publicado: (2020)

NAD(+) metabolism-based immunoregulation and therapeutic potential
por: Fang, Jiankai, et al.
Publicado: (2023)

NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
por: Vermot, Annelise, et al.
Publicado: (2021)

NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives
por: McCann, Sarah K., et al.
Publicado: (2013)

NAD(+) Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death
por: Xu, Weiyi, et al.
Publicado: (2020)

Neuroprotection in Glaucoma: NAD(+)/NADH Redox State as a Potential Biomarker and Therapeutic Target
por: Petriti, Bledi, et al.
Publicado: (2021)

Molecular evolution of Phox-related regulatory subunits for NADPH oxidase enzymes
por: Kawahara, Tsukasa, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_v0bge759f55v1v1p5m5ajko9c9